TD Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
TD Asset Management's SWTX Position: Q2 2025 in Review
TD Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 114,378 shares — an estimated $5.05M sold.
TD Asset Management first reported a position in SWTX in Q4 2020 and held it in 18 quarters. The position peaked at $12.5M in Q1 2024. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- TD Asset Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- TD Asset Management sold 114,378 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.05M.
- TD Asset Management first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 18 quarters.
- TD Asset Management's SpringWorks Therapeutics position peaked at $12.5M in Q1 2024.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on TD Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.